Vaccines, Blood & Biologics

Menveo

STN: 125300
Proper Name: Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
Tradename: Menveo
Manufacturer: Novartis Vaccines and Diagnostics, Inc.
Indication:

  • For active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 when administered to individuals 2 months to 55 years of age.

Supporting Documents

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 12/31/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.